| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 92.683 | 120.871 | 141.954 | 133.782 |
| Total Income - EUR | - | - | - | - | - | - | 92.683 | 120.871 | 141.954 | 151.990 |
| Total Expenses - EUR | - | - | - | - | - | - | 7.162 | 26.922 | 73.900 | 131.280 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 85.520 | 93.948 | 68.054 | 20.710 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 82.898 | 90.880 | 66.830 | 16.697 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Hippocrate Neurototal S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 601 | 3.399 | 40.902 | 31.944 |
| Current Assets | - | - | - | - | - | - | 82.971 | 88.524 | 49.581 | 37.041 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 69.102 | 0 | 16.151 |
| Cash | - | - | - | - | - | - | 82.971 | 19.422 | 49.581 | 20.890 |
| Shareholders Funds | - | - | - | - | - | - | 82.938 | 90.921 | 88.583 | 16.745 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 633 | 1.001 | 1.900 | 52.240 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hippocrate Neurototal S.r.l.